Ytang, Nathan Denz A.
HRN: 19-23-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/15/2023
11/22/2023
IVTT
560mg
Q6H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes